REFRACTORY ACUTE LEUKEMIA
Clinical trials for REFRACTORY ACUTE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY ACUTE LEUKEMIA trials appear
Sign up with your email to follow new studies for REFRACTORY ACUTE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with relapsed leukemia: drug combo trial launches
Disease control Recruiting nowThis study tests a new combination of three drugs (ziftomenib, venetoclax, and azacitidine) in children and young adults aged 2 to 21 with acute leukemia that has returned or not responded to treatment. The goal is to find the safest dose of ziftomenib when given with the other t…
Matched conditions: REFRACTORY ACUTE LEUKEMIA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New hope for kids with tough leukemia: chemo cocktail enters human testing
Disease control Recruiting nowThis early-stage study tests a combination of two chemotherapy drugs (hyper-CVAD and venetoclax) in children and young adults whose acute leukemia has returned or not responded to standard treatment. The main goal is to find a safe dose and watch for side effects. About 22 partic…
Matched conditions: REFRACTORY ACUTE LEUKEMIA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New combo therapy targets Hard-to-Treat leukemias
Disease control Recruiting nowThis study tests whether combining two drugs, revumenib and mezigdomide, is safe for people with certain types of acute leukemia that have come back or not responded to treatment. The trial includes about 52 participants aged 12 and older with specific genetic changes in their le…
Matched conditions: REFRACTORY ACUTE LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 13, 2026 16:03 UTC